Gray E, O’Leary A, Bergin C, et al. Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access program. Expert Rev Gastroenterol Hepatol. 2017:1–9. http://dx.doi.org/10.1080/17474124.2017.1292850
When the above article was first published online, several authors were missing from the author list. The author list and affiliations have now been updated as shown below in both the online and print versions.
E Graya, A O’Learyb,c, C Bergina,e, M Cannonf, G Courtneyg, O Crosbieh, CF De Gascuni, L J Fanningj, E Feeneyk, DD Houlihank, B Kelleherd, J S Lambertd,n, J Leel, PWG Mallond,n, S McConkeyf, A McCormickk, S McKiernane, C McNallyf, F Murrayf, G Sheehand, S Stewartd, C Walshm, S Norris a,e on behalf of the Irish Hepatitis C Outcomes and Research Network (ICORN)
Affiliations:
a. School of Medicine, Trinity College Dublin, Dublin, Ireland
b. National Centre for Pharmacoeconomics, St. James’ Hospital, Dublin, Ireland
c. School of Pharmacy, Royal College of Surgeons of Ireland, Dublin, Ireland
d. Mater Misericordiae University Hospital, Dublin, Ireland
e. St James’ Hospital, Dublin, Ireland
f. Beaumont Hospital, Dublin, Ireland
g. St. Luke’s Hospital, Kilkenny, Ireland
h. Cork University Hospital, Cork, Ireland
i. National Virus Reference Laboratory, University College Dublin, Dublin, Ireland
j. Molecular Virology Diagnostic & Research Laboratory, Department of Medicine, University College Cork, Cork, Ireland.
k. St. Vincent’s University Hospital, Dublin, Ireland
l. University College Hospital, Galway, Ireland
m. University of Limerick, Limerick, Ireland
n. School of Medicine, University College Dublin, Dublin, Ireland